26 January 2012
Johnson & Johnson was dealt a blow recently in its courtroom wrangling with rival heart stent makers Abbott, Boston Scientific and Medtronic over patents relating to the devices' drug coating.
Last week, a US district court judge in New Jersey ...
24 January 2012
Johnson & Johnson subsidiary DePuy Orthopaedics may be facing more problems with its metal-on-metal (MoM) hip implants, after a patient receiving its Pinnacle Ultamet device sued the company.
DePuy told Clinica that it "stands firmly behind the ...
20 January 2012
Stryker has agreed to pay $15m to settle an investigation over claims its biotech business fraudulently marketed its OP-1 spinal implant and bone putty, and submitted false reports to the US FDA .
As part of the agreement, Stryker Biotech will also ...
30 December 2011
A US sales unit of Synthes has accused orthopaedics rival Stryker for hiring ex-employees of the Swiss multinational and using confidential information about Synthes to gain "an improper competitive advantage" in the market for spinal implants and ...
20 December 2011
Kensey Nash has withdrawn its financial guidance for the rest of fiscal year 2012 as it seeks to resolve a dispute with St Jude Medical over royalty fees for the Angio-Seal vascular closure device.
Kensey developed Angio-Seal and receives royalties ...
